Owned by the Association for International Promotion & Study in Tumors (APSIT)
Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal malignancy, with an average 5-year survival rate of 9% (Siegel RL, Miller KD, Jemal A. Ca Cancer J Clin. 2019;69(1):7-34). The steady increase in ...
Citation: Journal of Experimental & Clinical Cancer Research 2021 40:8